TG Therapeutics, Inc. (TGTX)

35.33 +1.03 (+3.00%) USD  |  NASDAQ  |  Apr 17, 16:00
35.32 -0.01 (-0.03%) After-Hours: 20:00
More

TG Therapeutics SG&A Expense (Quarterly) : 62.74M for Dec. 31, 2025

SG&A Expense (Quarterly) Chart

View SG&A Expense (Quarterly) for TGTX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

SG&A Expense (Quarterly) Range, Past 5 Years

View SG&A Expense (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (Quarterly) Benchmarks

View SG&A Expense (Quarterly) Benchmarks
Start Trial
Precision BioSciences, Inc. 7.232M
Krystal Biotech, Inc. 41.45M
Geron Corp. 41.67M
Viking Therapeutics, Inc. 11.28M
Ocugen, Inc. 6.132M